FI120453B - Menetelmä kiteisten N-asetyylineuramiinihappojohdannaisten valmistamiseksi - Google Patents
Menetelmä kiteisten N-asetyylineuramiinihappojohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI120453B FI120453B FI962464A FI962464A FI120453B FI 120453 B FI120453 B FI 120453B FI 962464 A FI962464 A FI 962464A FI 962464 A FI962464 A FI 962464A FI 120453 B FI120453 B FI 120453B
- Authority
- FI
- Finland
- Prior art keywords
- hydrate
- aqueous solution
- guanidino
- galacto
- acetamido
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical class CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 title description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 51
- 239000013078 crystal Substances 0.000 claims description 43
- 239000002253 acid Substances 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 32
- 239000007864 aqueous solution Substances 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 24
- 238000002425 crystallisation Methods 0.000 claims description 15
- 230000008025 crystallization Effects 0.000 claims description 15
- 239000012296 anti-solvent Substances 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 239000007900 aqueous suspension Substances 0.000 claims description 5
- 150000004683 dihydrates Chemical class 0.000 claims description 2
- 150000002576 ketones Chemical group 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 235000007575 Calluna vulgaris Nutrition 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 description 20
- 238000003828 vacuum filtration Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 239000000725 suspension Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000002002 slurry Substances 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000003443 antiviral agent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- DQSQEHIDUNVGNQ-MJNXMCJASA-N (2S,3R)-3,4,5-trihydroxy-2-[(1S,2R,3R)-1,2,3,4-tetrahydroxybutyl]-3,6-dihydro-2H-pyran-6-carboxylic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1OC(C(O)=O)C(O)=C(O)[C@@H]1O DQSQEHIDUNVGNQ-MJNXMCJASA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9325841 | 1993-12-17 | ||
| GB939325841A GB9325841D0 (en) | 1993-12-17 | 1993-12-17 | Chemical compounds |
| PCT/EP1994/004154 WO1995016680A1 (en) | 1993-12-17 | 1994-12-15 | Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation |
| EP9404154 | 1994-12-15 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI962464L FI962464L (fi) | 1996-06-13 |
| FI962464A0 FI962464A0 (fi) | 1996-06-13 |
| FI120453B true FI120453B (fi) | 2009-10-30 |
Family
ID=10746778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI962464A FI120453B (fi) | 1993-12-17 | 1996-06-13 | Menetelmä kiteisten N-asetyylineuramiinihappojohdannaisten valmistamiseksi |
Country Status (43)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
| US5866601A (en) * | 1995-02-27 | 1999-02-02 | Gilead Sciences, Inc. | Carbocyclic compounds |
| PL194173B1 (pl) | 1995-02-27 | 2007-05-31 | Gilead Sciences | Preparat farmaceutyczny zawierający związki będące selektywnymi inhibitorami neuraminidaz wirusowych i bakteryjnych oraz zastosowania tych związków |
| US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| ES2167682T3 (es) * | 1996-07-22 | 2002-05-16 | Sankyo Co | Derivados del acido neuraminico, su preparacion y su uso medico. |
| US6340702B1 (en) | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6451766B1 (en) | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6518438B2 (en) | 1996-08-23 | 2003-02-11 | Gilead Sciences, Inc. | Preparation of cyclohexene carboxylate derivatives |
| US5859284A (en) * | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US5994377A (en) | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
| US5886213A (en) * | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| TW477783B (en) * | 1997-12-12 | 2002-03-01 | Gilead Sciences Inc | Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| US20080063722A1 (en) * | 2006-09-08 | 2008-03-13 | Advanced Inhalation Research, Inc. | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
| WO2013089168A1 (ja) * | 2011-12-16 | 2013-06-20 | 第一三共株式会社 | ノイラミン酸誘導体の製造方法 |
| CN109232677B (zh) * | 2018-10-18 | 2021-12-28 | 中国科学院合肥物质科学研究院 | 一种使n-乙酰神经氨酸水合物转化为n-乙酰神经氨酸的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU469694A1 (ru) * | 1972-12-22 | 1975-05-05 | Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им.М.В.Ломоносова | Способ получени 2-алкокси-6-алкил (арил)- -дигидропиранов |
| AP249A (en) * | 1990-04-24 | 1993-03-17 | Biota Scient Management Pty Ltd | Anti-viral compounds. |
| AU659501B2 (en) * | 1991-10-23 | 1995-05-18 | Biota Scientific Management Pty Ltd | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid |
| GB9126725D0 (en) * | 1991-12-17 | 1992-02-12 | Glaxo Group Ltd | Process |
| US5639786A (en) | 1992-12-04 | 1997-06-17 | Biota Scientific Management, Pty., Ltd. | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid |
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
-
1993
- 1993-12-17 GB GB939325841A patent/GB9325841D0/en active Pending
-
1994
- 1994-12-02 TW TW083111229A patent/TW452577B/zh not_active IP Right Cessation
- 1994-12-13 IS IS4240A patent/IS4240A/is unknown
- 1994-12-15 SK SK785-96A patent/SK282972B6/sk not_active IP Right Cessation
- 1994-12-15 CN CN94194973A patent/CN1132829C/zh not_active Expired - Lifetime
- 1994-12-15 EE EE9600135A patent/EE03353B1/xx unknown
- 1994-12-15 CA CA002177990A patent/CA2177990C/en not_active Expired - Lifetime
- 1994-12-15 HU HU9601642A patent/HU221971B1/hu active IP Right Grant
- 1994-12-15 PL PL94315055A patent/PL186384B1/pl unknown
- 1994-12-15 MA MA23724A patent/MA23396A1/fr unknown
- 1994-12-15 ZA ZA9410003A patent/ZA9410003B/xx unknown
- 1994-12-15 AT AT95904472T patent/ATE199255T1/de active
- 1994-12-15 CO CO94056728A patent/CO4340619A1/es unknown
- 1994-12-15 PT PT95904472T patent/PT734382E/pt unknown
- 1994-12-15 SI SI9430333T patent/SI0734382T1/xx unknown
- 1994-12-15 ES ES95904472T patent/ES2155517T3/es not_active Expired - Lifetime
- 1994-12-15 HR HR941001A patent/HRP941001B1/xx not_active IP Right Cessation
- 1994-12-15 RU RU96115122A patent/RU2134690C1/ru active Protection Beyond IP Right Term
- 1994-12-15 DK DK95904472T patent/DK0734382T3/da active
- 1994-12-15 AP APAP/P/1996/000810A patent/AP9600810A0/en unknown
- 1994-12-15 AP APAP/P/1994/000705A patent/AP541A/en active
- 1994-12-15 CZ CZ19961693A patent/CZ289234B6/cs not_active IP Right Cessation
- 1994-12-15 KR KR1019960703180A patent/KR100403256B1/ko not_active Expired - Lifetime
- 1994-12-15 NZ NZ277789A patent/NZ277789A/en not_active IP Right Cessation
- 1994-12-15 SG SG1996007725A patent/SG46669A1/en unknown
- 1994-12-15 EG EG79094A patent/EG20597A/xx active
- 1994-12-15 MY MYPI94003357A patent/MY116221A/en unknown
- 1994-12-15 JP JP51653195A patent/JP3317972B2/ja not_active Expired - Lifetime
- 1994-12-15 SV SV1994000076A patent/SV1994000076A/es active IP Right Grant
- 1994-12-15 WO PCT/EP1994/004154 patent/WO1995016680A1/en active IP Right Grant
- 1994-12-15 CN CNA2003101199989A patent/CN1502621A/zh active Pending
- 1994-12-15 UA UA96062328A patent/UA46723C2/uk unknown
- 1994-12-15 EP EP95904472A patent/EP0734382B1/en not_active Expired - Lifetime
- 1994-12-15 PE PE1994257245A patent/PE31095A1/es not_active Application Discontinuation
- 1994-12-15 DE DE69426726T patent/DE69426726T2/de not_active Expired - Lifetime
- 1994-12-15 BR BR9408340A patent/BR9408340A/pt not_active Application Discontinuation
- 1994-12-15 RO RO96-01195A patent/RO114792B1/ro unknown
- 1994-12-16 IL IL11201194A patent/IL112011A/en not_active IP Right Cessation
- 1994-12-28 SA SA94150417A patent/SA94150417B1/ar unknown
-
1996
- 1996-06-13 FI FI962464A patent/FI120453B/fi not_active IP Right Cessation
- 1996-06-14 NO NO19962545A patent/NO314759B1/no not_active IP Right Cessation
- 1996-06-14 OA OA60842A patent/OA10325A/fr unknown
- 1996-07-08 BG BG100709A patent/BG63338B1/bg unknown
-
1997
- 1997-05-13 BR BRPP1100548-KB1A patent/BR1100548KB1/pt unknown
-
1999
- 1999-07-02 US US09/346,583 patent/US6294572B1/en not_active Expired - Lifetime
-
2000
- 2000-01-06 OA OA1200000004A patent/OA11275A/fr unknown
-
2001
- 2001-03-30 GR GR20010400531T patent/GR3035681T3/el unknown
- 2001-09-24 US US09/961,074 patent/US20020037865A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI120453B (fi) | Menetelmä kiteisten N-asetyylineuramiinihappojohdannaisten valmistamiseksi | |
| JP3421354B2 (ja) | 結晶性セフジニルアミン塩 | |
| SU852175A3 (ru) | Способ получени гидратированнойКРиСТАлличЕСКОй фОРМы НАТРиЕВОйСОли 3-АцЕТОКСиМЕТил-7-/2-(2-АМиНО- 4-ТиАзОлил)-2-МЕТОКСииМиНОАцЕТАМидО/- цЕф-3-EM-4-КАРбОНОВОй КиСлОТы, СиН- изОМЕРА | |
| US4057548A (en) | Process for preparing methotrexate or an N-substituted derivative thereof and/or a di (lower) alkyl ester thereof and precursor therefor | |
| KR20190035680A (ko) | 벨리노스테트의 다형태 및 이의 제조 방법 | |
| US4067867A (en) | Process for preparing pyrazine precursor of methotrexate or an N-substituted derivative thereof and/or a di(lower)alkyl ester thereof | |
| EP0662967A1 (en) | Synthesis of n-acetyl neuraminic acid derivatives | |
| US6197998B1 (en) | Process for producing N-glycyltyrosine and its crystal structure | |
| DK170701B1 (da) | Bis(DMF)- og mono(DMF) solvater af et beta-lactamantibiotikum og fremgangsmåder til fremstilling af sådanne solvater | |
| GB2421024A (en) | Cefdinir crystalline form C | |
| NO146862B (no) | Jodbenzenderivater for anvendelse som roentgenkontrastmidler | |
| JP2010514753A (ja) | レルカニジピン塩酸塩の製造方法 | |
| AU689185C (en) | Crystalline N-acetyl neuraminic acid derivatives and processes for their preparation | |
| CN113045491B (zh) | 一种仑伐替尼及中间体的制备方法 | |
| US10889557B1 (en) | Method of producing an alkoxyflavone derivative | |
| HK1014187B (en) | Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation | |
| JP4610737B2 (ja) | 置換されたピリジンカルボン酸の改善された製造方法 | |
| JP2920565B2 (ja) | ２―ヒドロキシ―４―（３―クロロプロポキシ）―３―プロピルアセトフェノンの製造法 | |
| Vida et al. | Investigation in the 3, 4-dihydrocoumarin melilotic acid series | |
| KR960011779B1 (ko) | 세팔로스포린 결정성 수화물의 신규 제조방법 | |
| SK79098A3 (en) | 4,10'beta'-diacetoxy-2'alpha'-benzoyloxy-5'beta',20-epoxy-1- -hydroxy-9-oxo-19-nor-cyclopropa[g]tax-11-ene-13'alpha'-yl- (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate dihydrate, and method for preparing same | |
| JPH0332559B2 (cs) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 120453 Country of ref document: FI |
|
| MA | Patent expired |